BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 10523192)

  • 1. On the way to a better immunosuppressant?
    Hagmann M
    Science; 1999 Sep; 285(5436):2042. PubMed ID: 10523192
    [No Abstract]   [Full Text] [Related]  

  • 2. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A.
    Aramburu J; Yaffe MB; López-Rodríguez C; Cantley LC; Hogan PG; Rao A
    Science; 1999 Sep; 285(5436):2129-33. PubMed ID: 10497131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunosuppressive drugs and calcineurin].
    Masugi T; Otsuka K
    Tanpakushitsu Kakusan Koso; 1998 Sep; 43(12 Suppl):1739-43. PubMed ID: 9788176
    [No Abstract]   [Full Text] [Related]  

  • 4. Delivering on immunosuppression.
    Dell H
    Drug Discov Today; 2004 Apr; 9(8):345. PubMed ID: 15127718
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibitors of the calcineurin/NFAT pathway.
    Martínez-Martínez S; Redondo JM
    Curr Med Chem; 2004 Apr; 11(8):997-1007. PubMed ID: 15078162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive activity of endovanilloids: N-arachidonoyl-dopamine inhibits activation of the NF-kappa B, NFAT, and activator protein 1 signaling pathways.
    Sancho R; Macho A; de La Vega L; Calzado MA; Fiebich BL; Appendino G; Muñoz E
    J Immunol; 2004 Feb; 172(4):2341-51. PubMed ID: 14764703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of T-cell apoptosis by polyurethane biomaterials used in left ventricular assist devices is dependent on calcineurin activation.
    Schuster M; Ankersmit J; Kocher A; Lietz K; Schuster N; Hofmann M; John R; Edwards N; Oz M; Itescu S
    Transplant Proc; 2001; 33(1-2):1958-9. PubMed ID: 11267587
    [No Abstract]   [Full Text] [Related]  

  • 8. Integration of calcineurin and MEF2 signals by the coactivator p300 during T-cell apoptosis.
    Youn HD; Chatila TA; Liu JO
    EMBO J; 2000 Aug; 19(16):4323-31. PubMed ID: 10944115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin a inhibits calcineurin/nuclear factor of activated T-cells signaling and induces apoptosis in retinoblastoma cells.
    Eckstein LA; Van Quill KR; Bui SK; Uusitalo MS; O'Brien JM
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):782-90. PubMed ID: 15728531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new cell-permeable peptide allows successful allogeneic islet transplantation in mice.
    Noguchi H; Matsushita M; Okitsu T; Moriwaki A; Tomizawa K; Kang S; Li ST; Kobayashi N; Matsumoto S; Tanaka K; Tanaka N; Matsui H
    Nat Med; 2004 Mar; 10(3):305-9. PubMed ID: 14770176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoids inhibit calcium- and calcineurin-dependent activation of the human IL-4 promoter.
    Chen R; Burke TF; Cumberland JE; Brummet M; Beck LA; Casolaro V; Georas SN
    J Immunol; 2000 Jan; 164(2):825-32. PubMed ID: 10623828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms of the immunosuppressive action of cyclosporin A.
    Resch K; Szamel M
    Int J Immunopharmacol; 1997; 19(9-10):579-85. PubMed ID: 9637358
    [No Abstract]   [Full Text] [Related]  

  • 13. [A second target of cyclosporin A and FK506].
    Matsuda S; Koyasu S
    Tanpakushitsu Kakusan Koso; 2000 Aug; 45(11):1823-31. PubMed ID: 10936966
    [No Abstract]   [Full Text] [Related]  

  • 14. The novel calcineurin inhibitor CN585 has potent immunosuppressive properties in stimulated human T cells.
    Erdmann F; Weiwad M; Kilka S; Karanik M; Pätzel M; Baumgrass R; Liebscher J; Fischer G
    J Biol Chem; 2010 Jan; 285(3):1888-98. PubMed ID: 19923214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manipulating immune responses with immunosuppressive agents that target NFAT.
    Kiani A; Rao A; Aramburu J
    Immunity; 2000 Apr; 12(4):359-72. PubMed ID: 10795734
    [No Abstract]   [Full Text] [Related]  

  • 16. Study of the immunosuppressive properties of cyclosporine analogues.
    Reem GH; el Rouby S; Shi Y
    Ann N Y Acad Sci; 1993 Jun; 685():336-8. PubMed ID: 8363236
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective inhibition of calcineurin-NFAT signaling by blocking protein-protein interaction with small organic molecules.
    Roehrl MH; Kang S; Aramburu J; Wagner G; Rao A; Hogan PG
    Proc Natl Acad Sci U S A; 2004 May; 101(20):7554-9. PubMed ID: 15131267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CA++/ calcineurin/NFAT signaling in endothelial activation and angiogenesis: effects od cyclosporin A ].
    Quesada AJ; Redondo JM
    Nefrologia; 2003; 23 Suppl 3():44-8. PubMed ID: 12901192
    [No Abstract]   [Full Text] [Related]  

  • 19. A viral mechanism for inhibition of the cellular phosphatase calcineurin.
    Miskin JE; Abrams CC; Goatley LC; Dixon LK
    Science; 1998 Jul; 281(5376):562-5. PubMed ID: 9677199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A.
    Al-Daraji WI; Grant KR; Ryan K; Saxton A; Reynolds NJ
    J Invest Dermatol; 2002 May; 118(5):779-88. PubMed ID: 11982754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.